News Search

Researchers in Columbia's medical and engineering schools have edited a strain of non-pathogenic bacteria to colonize solid tumors in mice and safely deliver potent immunotherapies.

Since 1987, the Irving Scholars Program has supported patient-centered research of early-career faculty at VP&S, including physicians who developed into international leaders in their fields.

Anne Armstrong-Coben, MD’89, and Donald Quest, MD’70, are taking on leadership roles for Columbia's medical school.

Hematopoietic stem cells can survive extraordinary stress. Columbia scientists have learned how they escape death, which could lead to new treatments for blood cancers and diseases related to aging.